Gene · 1673
Papers4,248
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,248
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association of tumor budding with clinicopathological features and prognostic value in stage III-IV colorectal cancer. | World J Gastroenterol | 2024 | 38312121 | PubTator, text mining | PubMed |
| Structure-Guided Design and Synthesis of Pyridinone-Based Selective Bromodomain and Extra-Terminal Domain (BET)-First Bromodomain (BD1) Inhibitors. | J Med Chem | 2024 | 38295759 | PubTator, text mining | PubMed |
| Dynamic changes of Th1/Th2/Th17 cytokines and hBD-2/3 in erosive oral lichen planus patients saliva before and after prednisone acetate treatment. | Heliyon | 2024 | 38283247 | PubTator, text mining | PubMed |
| Establish a novel tumor budding-related signature to predict prognosis and guide clinical therapy in colorectal cancer. | Sci Rep | 2024 | 38273073 | PubTator, text mining | PubMed |
| Risankizumab: Mechanism of action, clinical and translational science. | Clin Transl Sci | 2024 | 38266061 | PubTator, text mining | PubMed |
| Update on vitamin D role in severe infections and sepsis. | J Anesth Analg Crit Care | 2024 | 38263252 | PubTator, text mining | PubMed |
| A novel film spray containing curcumin inhibits SARS-CoV-2 and influenza virus infection and enhances mucosal immunity. | Virol J | 2024 | 38263162 | PubTator, text mining | PubMed |
| Multimorbidity of Psoriasis: A Large-Scale Population Study of Its Associated Comorbidities. | J Clin Med | 2024 | 38256625 | PubTator, text mining | PubMed |
| Multi-Omics Approach to Improved Diagnosis and Treatment of Atopic Dermatitis and Psoriasis. | Int J Mol Sci | 2024 | 38256115 | PubTator, text mining | PubMed |
An In Vitro Model to Assess Early Immune Markers Following Co-Exposure of Epithelial Cells to Carbon Black (Nano)Particles in the Presence of S. aureus: A Role for Stressed Cells in Toxicological Testing. | Biomedicines | 2024 | 38255233 | PubTator, text mining | PubMed |
| Modulation of Interleukin-23 Signaling With Guselkumab in Biologic-Naive Patients Versus Tumor Necrosis Factor Inhibitor-Inadequate Responders With Active Psoriatic Arthritis. | Arthritis Rheumatol | 2024 | 38253404 | PubTator, text mining | PubMed |
| The Genetic Aspects of Periodontitis Pathogenesis and the Regenerative Properties of Stem Cells. | Cells | 2024 | 38247810 | PubTator, text mining | PubMed |
| Salivary Th17 cytokine, human β-defensin 1-3, and salivary scavenger and agglutinin levels in Crohn's disease. | Clin Oral Investig | 2024 | 38246944 | PubTator, text mining | PubMed |
| Cancer epigenetics: from laboratory studies and clinical trials to precision medicine. | Cell Death Discov | 2024 | 38225241 | PubTator, text mining | PubMed |
| Effects of tumour budding on adjuvant chemotherapy in colorectal cancer. | BJS Open | 2024 | 38190579 | PubTator, text mining | PubMed |
| Molecular Dynamics Simulations on Spike Protein Mutants Binding with Human β Defensin Type 2. | J Phys Chem B | 2024 | 38189674 | PubTator, text mining | PubMed |
| Periodontal health status in patients with lung cancer: Case-control study. | Int J Health Sci (Qassim) | 2024 | 38188898 | PubTator, text mining | PubMed |
| Discovery of Novel Phenoxyaryl Pyridones as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with High Selectivity for the Second Bromodomain (BD2) to Potentially Treat Acute Myeloid Leukemia. | J Med Chem | 2024 | 38175809 | PubTator, text mining | PubMed |
| DW71177: A novel [1,2,4]triazolo[4,3-a]quinoxaline-based potent and BD1-Selective BET inhibitor for the treatment of acute myeloid leukemia. | Eur J Med Chem | 2024 | 38134745 | PubTator, text mining | PubMed |
| Increased S. aureus colonization and reduced antimicrobial peptide expression in erythrodermic psoriasis. | Int Immunopharmacol | 2024 | 38096593 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1673/papers?page=10